Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Nanjing King-friend Biochemical Pharmaceutical Co Ltd
603707Current price
14.73 CNY
-0.09 CNY (-0.61%)
Last closed
14.82 CNY
Company
www.nkf-pharma.com
ISIN
CNE100002WP3
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
Shanghai Stock Exchange
Capitalization
25 002 112 286 CNY
Yield for 12 month
+6.82 %
1Y
3Y
5Y
10Y
15Y
603707
Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of drugs and APIs in China. The company provides heparin sodium, enoxaparin sodium, dalteparin sodium, nadroparin calcium, atracurium, cisatracurium, fulvestrant, doxercalciferol, milrinone lactate, fondaparinux sodium, phenylephrine, gemcitabine, levoleucovorin, carboplatin, cytarabine, bleomycin, topotecan hydrochloride, bendamustine HCL, bortezomib, clofarabine, busulfan, dactinomycin, azacitidine, mycophenolate mofetil, tigecycline, glycopyrrolate, melphalan, daptomycin, decitabine, haloperidol decanoate, carmustine, bivalirudin, dexmedetomidine, and neostigmine methylsulfate injections. It also offers isosulfan blue, succinylcholine chloride, furosemide, regadenoson, voriconazole, ganirelix acetate, eptifibatide, enoxaparin sodium, mitomycin, vancomycin, micafungin sodium, docetaxel, nelarabine, pemetrexed, rocuronium bromide, zoledronic acid, thiamine, fluorouracil, perixafor, thiotepa, pantoprazole sodium, glatiramer acetate, and bupivacaine hydrochloride injections. The company was founded in 2000 and is based in Nanjing, China. Address: No.16 Xuefu Road,High&New Tech Development Zone, Nanjing, China, 210061
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
150.8 CNYP/E ratio
–Dividend Yield
–Current Year
+3 942 890 219 CNY
Last Year
+3 723 583 591 CNY
Current Quarter
+1 141 717 778 CNY
Last Quarter
+1 007 210 209 CNY
Current Year
+1 908 233 526 CNY
Last Year
+1 950 412 858 CNY
Current Quarter
+476 915 057 CNY
Last Quarter
+387 717 972 CNY
Key Figures 603707
1 year
3 years
5 years
10 years
EBITDA
-342 177 466 CNY
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-3.05 %
PEG Ratio
–
Return On Equity TTM
-6.46 %
Wall Street Target Price
150.8 CNY
Revenue TTM
3 888 823 603 CNY
Book Value
3.89 CNY
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
12.8 %
Dividend Yield
–
Gross Profit TTM
2 089 439 673 CNY
Earnings per share
-0.27 CNY
Diluted Eps TTM
-0.27 CNY
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
-8.3 %
Profit Margin
-10.91 %
Dividend Analytics 603707
Dividend growth over 5 years
119 %Continuous growth
–Payout Ratio 5 years average
-6 %Dividend History 603707
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
08.07.2024
Forward Annual Dividend Yield
–
Last Split Factor
1.3:1
Payout Ratio
–
Last Split Date
11.07.2022
Dividend Date
–
Stock Valuation 603707
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
6.5199
Price Sales TTM
6.3792
Enterprise Value EBITDA
17.7699
Price Book MRQ
3.9757
Financials 603707
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 603707
For 52 weeks
10.48 CNY
16.45 CNY
50 Day MA
13.56 CNY
Shares Short Prior Month
–
200 Day MA
12.93 CNY
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart